The attorney general claims that the physicians who were testing the ProDisc were, in many cases, recommending its use to patients, and nearly half of those testing the product were being compensated with company stock for doing so.
Synthes has agreed to disclose any future payments or investments held by doctors involved in researching its products through its Web site and will pay $236,000 to reimburse the attorney general’s office for its investigation.
Read the New York Times’ report on the Synthes settlement.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
